Healwell AI Inc. (AIDX) Earnings Call Transcripts
Healwell AI Inc.'s Latest Earnings Call - Q1 FY2026
In Q1 2026, Healwell AI Inc. reported a significant revenue increase to $33.2 million, up 36% year-over-year, driven by the Orion Health acquisition and organic growth in its AI division. The company achieved positive adjusted EBITDA of $0.7 million, a substantial improvement from a loss of $2.3 million in Q1 2025. Management maintained a positive outlook, indicating a strong pipeline and plans to accelerate enterprise development in the U.S., Australia, and the Middle East, while targeting a 10% adjusted EBITDA margin by year-end.
Reported metrics
| Metric | Value |
|---|---|
| Revenue | $33.2 million (beat) |
| Adjusted EBITDA | $0.7 million (beat) |
| Gross Profit | $19.5 million (beat) |
| Gross Margin | 59% (beat) |
| Net Loss | $6.8 million (beat) |
| Cash Position | $21.9 million (positive) |
Guidance from management
Management is targeting a 10% adjusted EBITDA margin by year-end and expects to continue accelerating enterprise pipeline development across key markets.
What management said
Let me cover that. Obviously, it's early in the year. What I would say is the pipeline still gives us confidence in our previous comments about growth. Revenue recognition is always tricky to get that kind of precision in the survey in the year. So we're not -- we're not at the stage where we can update that. But what I can say is that the pipeline continues nicely [indiscernible] Software development, we'll probab...
Yes. Gianluca, thanks for that Yes, definitely had a great quarter from that perspective, a little bit of a catch-up taking place. We can expect to see that our margins will be in that mid the 50% range that we've seen historically. I think we had a nice little benefit in this quarter, but I think we'll be in that mid-50s range for the year as we get -- as we look ahead.
What analysts pressed on
Analysts expressed concerns about the sequential decline in subscription revenue for the AI and Data Science segment and sought clarification on the sustainability of recent gross margin improvements. There were also questions regarding the sales cycle length in the Middle East and how it impacts revenue recognition.
Main topics on the call
- Revenue Growth — Healwell achieved quarterly revenues of $33.2 million, a 36% increase from $8 million in Q1 2025, largely driven by the Orion Health acquisition. CEO James Lee stated, "Q1 was another strong revenue quarter, and we maint...
- Adjusted EBITDA Improvement — The company reported positive adjusted EBITDA of $0.7 million, a 132% improvement from a loss of $2.3 million in the prior year. CFO Anthony Lam noted, "The improvement in adjusted EBITDA is attributable to the Orion Hea...
- Gross Margin Expansion — Gross profit reached $19.5 million, reflecting a 340% increase year-over-year, with gross margin percentage improving to 59% from 56%. Lam highlighted that this growth was due to higher revenue performance across the bus...
- Strategic Partnerships and Market Expansion — Healwell is deepening partnerships with life sciences organizations and expanding its footprint in the U.S. and Middle East. Lee mentioned, "We will be accelerating enterprise pipeline development across the U.S., Austra...
Read the full Healwell AI Inc. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Healwell AI Inc.
Healwell AI Inc. (AIDX) is a publicly listed company in the Health Care Providers and Services industry, within the Health Care sector. It trades on TSX and is based in CA. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 17 calls on record spanning November 15, 2021 to August 7, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 17 Healwell AI Inc. earnings call transcripts on record, spanning November 15, 2021 to August 7, 2026. Based on this history, Healwell AI Inc. reports quarterly. The most recent call on file is dated August 7, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- AIDX
- Exchange
- TSX
- Country
- CA
- Sector
- Health Care
- Calls on record
- 17
- First call
- November 15, 2021
- Most recent
- August 7, 2026
- Reporting cadence
- quarterly
| Quarter | Date | |
|---|---|---|
| Q2 FY2026 | Aug 7, 2026 | Read transcript → |
| Shareholder/Analyst Calls | Jun 25, 2026 | Read transcript → |
| Q1 FY2026 | May 8, 2026 | Read transcript → |
| Q4 FY2025 | Mar 20, 2026 | Read transcript → |
| Shareholder/Analyst Calls | Jun 30, 2025 | Read transcript → |
| Q1 FY2025 | May 13, 2025 | Read transcript → |
| Q4 FY2024 | Mar 26, 2025 | Read transcript → |
| Q3 FY2024 | Nov 12, 2024 | Read transcript → |
| Q2 FY2024 | Aug 12, 2024 | Read transcript → |
| Q1 FY2024 | May 14, 2024 | Read transcript → |
| Q4 FY2023 | Mar 28, 2024 | Read transcript → |
| Q3 FY2023 | Nov 15, 2023 | Read transcript → |
| Q3 FY2022 | Nov 14, 2022 | Read transcript → |
| Q2 FY2022 | Aug 15, 2022 | Read transcript → |
| Q1 FY2022 | May 16, 2022 | Read transcript → |
| Q4 FY2021 | Mar 31, 2022 | Read transcript → |
| Q3 FY2021 | Nov 15, 2021 | Read transcript → |